Platinum-resistant Ovarian Cancer research hub

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

This study is testing a new medicine called lorigerlimab for some women with advanced ovarian or gynaecological cancers that have not responded well to certain other treatments. The aim is to see if it's safe and helps shrink the cancer.